Performa LTD (Us), LLC Exelixis, Inc. Transaction History

Performa LTD (Us), LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$15.68 - $22.27 $9,408 - $13,362	600 New	600 $9,000
Q4 2021 Jan 31, 2022	SELL	$15.84 - $21.88 $1,584 - $2,188	-100 Reduced 44.44%	125 $2,000
Q3 2021 Oct 28, 2021	BUY	$16.3 - $21.14 $1,222 - $1,585	75 Added 50.0%	225 $5,000
Q2 2021 Jul 28, 2021	BUY	$17.95 - $25.56 $2,692 - $3,834	150 New	150 $3,000
Q2 2021 Jul 27, 2021	SELL	$17.95 - $25.56 $2,692 - $3,834	-150 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$20.53 - $25.22 $9,238 - $11,349	-450 Reduced 75.0%	150 $3,000
Q4 2020 Jan 27, 2021	BUY	$18.39 - $24.8 $11,034 - $14,880	600 New	600 $12,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Performa LTD (Us), LLC, based on Form 13F filings with the SEC.

Stay updated on Performa LTD (Us), LLC with notifications on news.